Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma - PubMed (original) (raw)

. 2019 Jan;120(1):109-114.

doi: 10.1038/s41416-018-0199-2. Epub 2018 Oct 31.

Stephanie Roessler 3 4, Marcus Renner 3, Stephan Singer 3, Arianeb Mehrabi 5 4, Monika Nadja Vogel 6, Anita Pathil 7, Elena Czink 8 4, Bruno Köhler 8 4, Christoph Springfeld 8 4, Jan Pfeiffenberger 7 4, Christian Rupp 7 4, Karl Heinz Weiss 7 4, Peter Schirmacher 3 4, Magnus von Knebel Doeberitz 9, Matthias Kloor 9

Affiliations

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

Benjamin Goeppert et al. Br J Cancer. 2019 Jan.

Abstract

Background: A major molecular pathway of genetic instability in cancer is DNA mismatch repair deficiency. High-level microsatellite instability (MSI-H) is currently the best predictor of responsiveness towards immune checkpoint blockade. Data about the prevalence of high-level microsatellite instability in cholangiocarcinoma (CCA) has been conflicting.

Methods: We employed a cohort comprising 308 Western-world, non-liver fluke-associated CCAs (159 intrahepatic, 106 perihilar, and 43 distal). We analysed the mononucleotide microsatellite instability marker panel consisting of BAT25, BAT26, and CAT25 and detected MSI-H in 4/308 CCAs (1.3%).

Results: Patients affected by MSI-H CCA had mostly an atypical histomorphology (p = 0.004), showed a longer overall survival, although having a high tumour stage, and were of younger age. Correlation analysis of microsatellite instability status with tumour-infiltrating immune cells, MHC I, and PD-L1 expression in the same cholangiocarcinoma cohort showed higher numbers of CD8 + T cells, FOXP3 + regulatory T cells, CD20 + B cells and high or at least moderate MHC I expression levels in MSI-H CCAs.

Conclusions: Even though the overall number of MSI-H CCAs is low, the dismal prognosis of the disease and the therapeutic option of immune checkpoint blockade in the respective patients justify MSI testing of cholangiocarcinoma, particularly in younger patients showing an atypical histomorphology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1

Fig. 1

Immunohistochemistry of two representative microsatellite-unstable cases. Full slide sections of one microsatellite-unstable intrahepatic cholangiocarcinoma with papillary morphology (left sided column: a, c, e, g, i) showing loss of nuclear MLH1 and PMS2 immunoreactivity while MSH2 and MSH6 were retained. Full slide sections of one microsatellite-unstable perihilar cholangiocarcinoma (right sided column: b, d, f, h, j) showing loss of nuclear PMS2 immunoreactivity while MLH1, MSH2, and MSH6 were retained. Original magnification: 40× (H&E; a, b), 100x (c–j), 200× (insets of d and f)

Fig. 2

Fig. 2

Overall survival probability in cholangiocarcinoma patients in correlation with high-level microsatellite instability status. Kaplan–Meier curves show a longer overall survival of microsatellite-unstable cholangiocarcinoma patients in correlation with microsatellite-stable cholangiocarcinoma patients (p = 0.097). _P_-value was calculated by log-rank test. Survival data were available for 285 of 308 (92.5%) cholangiocarcinoma patients

References

    1. Le DT, et al. Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409–413. doi: 10.1126/science.aan6733. - DOI - PMC - PubMed
    1. Banales JM, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) Nat. Rev. Gastroenterol. Hepatol. 2016;13:261–280. doi: 10.1038/nrgastro.2016.51. - DOI - PubMed
    1. Chan E, Berlin J. Biliary tract cancers: understudied and poorly understood. J. Clin. Oncol. 2015;33:1845–1848. doi: 10.1200/JCO.2014.59.7591. - DOI - PubMed
    1. Nakamura H, et al. Genomic spectra of biliary tract cancer. Nat. Genet. 2015;47:1003–1010. doi: 10.1038/ng.3375. - DOI - PubMed
    1. Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 2016;22:1342–1350. doi: 10.1038/nm.4191. - DOI - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources